Most importantly, clinical studies suggest that hypertension was more common in patients taking COX-2 inhibitors such as celecoxib and etoricoxib, and COX inhibition may attenuate the effects of some antihypertensive therapeutics (Mitchell et al. 2020; Chan et al. 2009). The gene discussed is PTGS2; the disease is Hypertension.